Loading…
Loading…
The Law Offices of Frank R. Cruz announces an investigation of Morphic Holding, Inc. (“Morphic” or the “Company”) MORF on behalf of investors concerning the Company’s possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
On September 22, 2023, Morphic issued a press release announcing publication of an abstract discussing the Company’s EMERALD-1 phase 2a primary results. The Company revealed disappointing results, including that “endoscopic improvement was achieved in 25.7% of patients at week 12,” which was less than the 41% shown by Entyvio.
On this news, Morphic’s stock price fell $28.26, or 54.4%, over two consecutive trading days to close at $23.14 per share on September 25, 2023, thereby injuring investors.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
If you purchased Morphic securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240104114760/en/
Loading…
Loading…
